Skip to main
HLF
HLF logo

Herbalife (HLF) Stock Forecast & Price Target

Herbalife (HLF) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 47%
Buy 13%
Hold 27%
Sell 7%
Strong Sell 7%

Bulls say

Herbalife Ltd has demonstrated robust financial performance, with an EBITDA of $167 million for the fourth quarter, exceeding consensus estimates by $26 million, and the company raised its 2024 EBITDA guidance by $25 million at the mid-point. Additionally, the company has reported a positive trend in distributor growth, achieving a year-over-year increase of 22% for the third consecutive quarter, signaling a strengthening direct-selling business model. The improved EBITDA margin of 13.4% reflects a combination of positive pricing strategies and lower input costs, suggesting strong operational efficiency and resilience in the face of economic challenges.

Bears say

Herbalife Ltd reported a sales decline in 3Q24, with constant currency sales of -0.3% falling short of estimates due to weaknesses in vital markets such as China and North America. The company has revised its 2024 sales guidance downward, anticipating a mid-point of -1.5%, alongside a decline in volume points of -5.4%, indicating worsening sales performance. Additionally, risks associated with distributor relations, regulatory compliance, and consumer demand, especially for significant products like the Formula 1 Nutritional Shake Mix, pose substantial threats to the company's financial stability.

Herbalife (HLF) has been analyzed by 15 analysts, with a consensus rating of Buy. 47% of analysts recommend a Strong Buy, 13% recommend Buy, 27% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Herbalife and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Herbalife (HLF) Forecast

Analysts have given Herbalife (HLF) a Buy based on their latest research and market trends.

According to 15 analysts, Herbalife (HLF) has a Buy consensus rating as of Jul 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Herbalife (HLF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.